Compare MNKD & NAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MNKD | NAC |
|---|---|---|
| Founded | 1991 | 1998 |
| Country | United States | France |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.7B |
| IPO Year | 2004 | N/A |
| Metric | MNKD | NAC |
|---|---|---|
| Price | $5.68 | $11.83 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $10.08 | N/A |
| AVG Volume (30 Days) | ★ 3.3M | 307.3K |
| Earning Date | 11-05-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.33% |
| EPS Growth | ★ 23.47 | N/A |
| EPS | ★ 0.10 | N/A |
| Revenue | ★ $313,787,000.00 | N/A |
| Revenue This Year | $21.54 | N/A |
| Revenue Next Year | $22.21 | N/A |
| P/E Ratio | $57.92 | ★ N/A |
| Revenue Growth | ★ 17.43 | N/A |
| 52 Week Low | $3.38 | $9.32 |
| 52 Week High | $6.68 | $11.21 |
| Indicator | MNKD | NAC |
|---|---|---|
| Relative Strength Index (RSI) | 48.22 | 50.90 |
| Support Level | $5.56 | $11.73 |
| Resistance Level | $6.12 | $11.79 |
| Average True Range (ATR) | 0.17 | 0.08 |
| MACD | -0.04 | 0.00 |
| Stochastic Oscillator | 20.51 | 46.15 |
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.
Nuveen California Quality Municipal Income Fund is a diversified closed-end management investment company. Its objective is to provide current income exempt from regular federal and California income tax and to enhance portfolio value relative to the municipal bond market by investing in municipal securities that are exempt from federal and California state income taxes. It invests majority of its assets in securities that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.